Enovis Corp (ENOV)

NYSE

$26.84

Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.

Sector:

Industry:

68 analysts

Buy

Target: $40.73 (+51.75%)

Market Cap

$1.47B

P/B Ratio

1.00

Free Cash Flow Yield

2.44%

Beta (5Y)

1.40

Adjust inflation

Log

Valuation

Market Cap$1.47B

Forward P/E7.34

P/S0.68

P/B1.00

Profitability

Total Revenue (TTM)$2.28B

Gross Profit (TTM)$1.39B

EBITDA$275M

Profit Margin-1.5%

Operating Margin1.1%

EPS-$19.88

Financial Health

Debt-to-Equity89.8%

Free Cash Flow Yield2.44%

Growth & Risk

Revenue 5Y CAGR+14.00%

FCF 5Y CAGR-30.52%

Beta (5Y)1.40

Sharpe Ratio0.00